Delivery Order SPE2DB24D2010-SPE2DB25FABCS
Award Date 9/8/25
Potential Completion Date 9/9/25
Potential Value $23K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Monovisc 88 mg/4 ml syringes with a ceiling value of $2,021.59. This is a firm fixed price delivery order with an ultimate completion date of August 21, 2025, and represents a competitively awarded, non-set-aside contract. AmerisourceBergen's corporate office in Conshohocken, Pennsylvania serves as the place of performance for this pharmaceutical supply delivery. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 22, 2025, for the supply of Monovisc 88 mg/4 ml syringes with a ceiling value of $2,058.76. This is a firm fixed price delivery order with an ultimate completion date of August 25, 2025, and carries no set-aside designation. The award was made to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters and distribution operations for...
- The Defense Logistics Agency awarded a delivery order valued at $3,757.37 to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Monovisc 88 mg/4 mL syringes. The order, which represents a child contract under a larger indefinite delivery vehicle, is scheduled for completion by July 30, 2025, and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. This award was made on a firm fixed-price basis with no set-aside designation, indicating it was...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $7,229.88 on July 29, 2025, for the supply of Monovisc 88 mg/4 ml syringes. This competitive award, with no set-aside designation, represents a firm fixed price contract with an ultimate completion date of July 30, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting...
- The Defense Logistics Agency (DLA) awarded a $10,158.47 delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Monovisc 88 mg/4 mL syringes. This is a firm fixed-price, competitively awarded contract with no set-aside designation, with performance scheduled for completion by July 29, 2025. The product will be delivered to the Conshohocken, Pennsylvania location, where AmerisourceBergen maintains its corporate headquarters. This delivery order is a child contract issued...
- The Defense Logistics Agency awarded a $8,318.78 delivery order to AmerisourceBergen Drug Corp for MONOVISC 88 mg/4 mL syringes (4 mL quantity) on July 21, 2025, with an ultimate completion date of July 22, 2025. This non-set-aside, competitively awarded contract features firm fixed pricing and represents a routine pharmaceutical supply delivery. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a $41,326.09 delivery order by the Defense Logistics Agency on August 7, 2025, for the supply of Monovisc 88 mg/4 mL syringes. This firm fixed-price contract, which is not a set-aside award, represents a competitive procurement executed under a larger indefinite delivery contract vehicle. The delivery order carries an ultimate completion date of August 8, 2025, with the...
- AmerisourceBergen Drug Corp was awarded a $3,443.09 delivery order by the Defense Logistics Agency (DLA) on August 15, 2025, for the supply of Monovisc 88 mg/4 mL syringes. The contract is a firm fixed price delivery order with an ultimate completion date of August 18, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. This award represents a non-set-aside, competitively awarded contract, reflecting AmerisourceBergen's demonstrated capability to meet...
- The Defense Logistics Agency awarded a $9,521.32 delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Monovisc 88 mg/4 mL syringes (4 mL units). This firm fixed-price contract, which must be completed by September 10, 2025, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The award was competitively procured without set-aside restrictions, reflecting the contractor's established capability to...
- The Defense Logistics Agency awarded a delivery order valued at $9,013.11 to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Monovisc 88 mg/4 ml syringes. The contract is a firm fixed-price delivery order with a completion date of August 6, 2025, and will be performed at the contractor's location in Conshohocken, Pennsylvania. This award was made through open competition with no set-aside designation, reflecting AmerisourceBergen's capability to compete for federal medical...